Detalhe da pesquisa
1.
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5).
Blood
; 143(6): 496-506, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879047
2.
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.
Am J Hematol
; 99(3): 380-386, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258329
3.
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 23(1): 91-103, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895487
4.
Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.
Blood
; 128(18): 2199-2205, 2016 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601462
5.
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Haematologica
; 103(9): 1511-1517, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880613
6.
Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.
Am J Hematol
; 93(11): 1394-1401, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132965
7.
Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutrition.
Biol Blood Marrow Transplant
; 21(4): 768-71, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25543093
8.
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium.
Blood Adv
; 8(4): 1042-1050, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051550
9.
Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.
Hematol Oncol
; 36(2): 495-497, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664979
10.
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.
J Clin Oncol
; 38(27): 3119-3128, 2020 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32401634
11.
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.
Cancer Med
; 9(22): 8468-8479, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969597
12.
A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia.
PLoS One
; 11(4): e0153016, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27050425
13.
DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia.
Clin Cancer Res
; 21(7): 1614-20, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25609058